Rehan Raina: Did You Know Your Immune Cells are What Actually Kill Cancer?
Rehan Raina, Quality and Marketing Manager at Salalah Macaroni Co SAOC, shared a post on LinkedIn about recent articles, adding։
“Did you know your immune cells are what actually kill cancer?
As a surgeon who removed hundreds of cancers, this is something I lived firsthand and it took me years to fully reckon with it.
When an oncologist orders a CBC, they are looking at red blood cells for anemia, platelets to prevent bleeding, and neutrophils to avoid infection.
All valid. All important for managing treatment side effects.
But none of those cells kill cancer.
The cells that kill cancer are your natural killer cells and T cells.
They live inside that same CBC under the lymphocyte count.
And for decades, most oncologists never looked at them.
Not out of negligence, but because there was no drug or intervention that could meaningfully increase them.
So the number sat there, ignored.
That is changing now in a significant way.
Researchers have developed a way to extract a patient’s own T cells, engineer them in a lab to recognize and attack cancer cells specifically, and reinfuse them back into the body.
This is called CAR-T cell therapy, and it is already producing outcomes in certain blood cancers that conventional treatment never achieved.
The broader lesson here is one I think about constantly.
Your immune system is your first and most powerful defense against cancer.
The lifestyle choices that protect and strengthen it, sleep, nutrition, stress management, and movement, are not soft wellness advice.
They are oncology.”
Title: Cancer immunotherapy using checkpoint blockade
Authors: Antoni Ribas, Jedd D Wolchok

Title: The future of immune checkpoint therapy
Authors: Padmanee Sharma, James P Allison

Title: NK cells for cancer immunotherapy
Authors: Noriko Shimasaki, Amit Jain, Dario Campana

Title: Treatment of the “syndrome of doubles”
Authors: G N Christodoulou

Proceed to the video attached to the post.
Stay updated on all scientific advances Hemostasis Today.
-
Apr 20, 2026, 18:59Chokri Ben Lamine: Contributing to a Landmark Chapter on Amegakaryocytic Thrombocytopenia in Bone Marrow Failure
-
Apr 20, 2026, 18:39David McIntosh: A Watershed Moment for Global Plasma Community and Call for Unified Action
-
Apr 20, 2026, 18:15Nandini Pethe: Grateful for a Fantastic 2026 HFA Symposium Filled with Impactful Educational Sessions and Meaningful Connections
-
Apr 20, 2026, 17:13Armghan Ans: The Stroke Decision Nobody Owns
-
Apr 20, 2026, 17:12Assefa Desalew: RhD-Negative Status and Adverse Perinatal Outcomes in Eastern Ethiopia
-
Apr 20, 2026, 16:55Francesco Lo Monaco: Blood Type and Heart Risk – Small Differences, Bigger Role of Lifestyle
-
Apr 20, 2026, 16:44Supporting the Next Generation in Thrombosis and Hemostasis at ISTH 2026
-
Apr 20, 2026, 16:38Bjorn Logi Thorarinsson: Strengthening Stroke Units Through Certification, Registries, and Evidence-Based Practice
-
Apr 20, 2026, 16:37Domenico Girelli: Anemia Is Linked to Higher Dementia Risk and Elevated Alzheimer’s Disease Biomarkers